GLP-1 drugs may be hailed as a medical breakthrough in obesity care, but Indian experts warn they are no cosmetic quick-fix.

Mumbai's top celebrity aestheticians shed light on the craze for anti-ageing and how one can avoid any kind of complications ...

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...

If you’ve been taking Ozempic or Wegovy (both of which contain the active ingredient semaglutide), you might wonder, How long ...

A box of Ozempic, a semaglutide injection drug used for treating type 2 diabetes and made by Novo Nordisk, is seen at a Rock Canyon Pharmacy in Provo, Utah, U.S. March 29, 2023.

Despite its success, most current Semaglutide formulations still require weekly injections or large daily oral tablets, which can affect patient adherence. A rapidly dissolving oral thin film promises ...

PLAINSBORO, N.J., June 26, 2025 /PRNewswire/ -- Novo Nordisk continues expansion of patient access to Wegovy ® (semaglutide) injection 2.4 mg through a new collaboration with WeightWatchers, a ...

Despite its success, most current Semaglutide formulations still require weekly injections or large daily oral tablets, which can affect patient adherence.

1. 7 million patients reveal stunning link between semaglutide and lower dementia risk Date: June 25, 2025 Source: Case Western Reserve University Summary: A blockbuster diabetes and weight-loss ...

Semaglutide, a common diabetes and weight loss medication, can have several long-term side effects. Despite this, experts generally consider it safe and effective.

Regarding injection site rotation, alternate between different areas like the abdomen, thigh, or upper arm to prevent ...